Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

Recs

0
Player Avatar gopyerk (48.78) Submitted: 4/15/2011 4:45:22 PM : Outperform Start Price: $31.57 CBST Score: +24.73

Some great buzz about this company right now. Good clinicals taking place, nice earnings and some great growth potential. I like this for the long term...

Featured Broker Partners


Advertisement